Trial site
Liepajas Regionala Slimnica SIA
- 14running trials
- 10closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis6 trials
- Deep vein thrombosis and pulmonary embolism5 trials
- Atrial fibrillation3 trials
- Bladder cancer3 trials
- Stroke3 trials
- Crohn's disease2 trials
- COPD1 trial
- Gastroparesis1 trial
- Heart failure1 trial
- Lupus (SLE)1 trial
- Prostate cancer1 trial
- Phase
- Phase 315 trials
- Phase 29 trials
- Phase 41 trial
- Status
- Completed10 trials
- Recruiting6 trials
- Active, not recruiting5 trials
- Not yet recruiting3 trials
- Suspended1 trial
- Lead sponsor
- AbbVie4 trials
- Regeneron Pharmaceuticals3 trials
- Anthos Therapeutics, Inc.2 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2 trials
- UroGen Pharma Ltd.2 trials
- and 12 more
Running trials
Recruiting
Recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
A study to test if SRSD107 prevents venous thromboembolism events and how safe it is
Active, not recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation2 recruiting
- Crohn's disease2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Stroke2 recruiting
- Bladder cancer1 recruiting
- Heart failure1 recruiting
- Prostate cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Terminated
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026